Recovery of interfering bacteria in the nasopharynx following antimicrobial therapy of acute maxillary sinusitis with telithromycin or amoxicillin- clavulanate

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 11, 2005, Pages 4793-4794

  Brook, Itzhak ^a   Hausfeld, Jeffrey N ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; TELITHROMYCIN;

ADOLESCENT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GROWTH INHIBITION; HIGH RISK PATIENT; HUMAN; MALE; MAXILLA SINUSITIS; NASOPHARYNX; PREVOTELLA MELANINOGENICA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIA; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; KETOLIDES; MALE; MAXILLARY SINUSITIS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; NASOPHARYNX; PREVOTELLA; STREPTOCOCCUS PNEUMONIAE;

EID: 27644588267     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.11.4793-4794.2005     Document Type: Article

References (17)

1. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1998. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. Antimicrob. Agents Chemother. 42:2138-2140.
2. Bernstein, J. M., S. Sagahtaheri-Altaie, D. M. Dryja, and J. Wactawski-Wende. 1994. Bacterial interference in nasopharyngeal bacterial flora of otitis-prone and non-otitis-prone children. Acta Otorhinolaryngol. Belg. 48:1-9.
3. Brook, I., L. Calhoun, and P. Yocum. 1980. Beta-lactamase-producing isolates of Bacteroides species from children. Antimicrob. Agents Chemother. 18:164-166.
4. Brook, I., and A. E. Gober. 1995. Role of bacterial interference and betalactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Arch. Otolaryngol. Head Neck Surg. 121:1405-1409.
5. Brook, I., and A. E. Gober. 1999. Bacterial interference in the nasopharynx and nasal cavity of sinusitis prone and non-sinusitis prone children. Acta Otolaryngol. 119:832-836.
6. Brook, I. 2001. The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int. J. Antimicrob. Agents 17:439-442.
7. Brook, I. 1999. Bacterial interference. Crit. Rev. Microbiol. 25:155-172.
8. Credito, K. L., L. M. Ednie, M. R. Jacobs, and P. C. Appelbaum. 1999. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. Antimicrob. Agents Chemother. 43:2027-2031.
9. Faden, H., M. J. Zaz, J. M. Bernstein, L. Brodsky, J. Stamievich, and P. L. Ogru. 1991. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann. Otol. Rhinol. Laryngol. 100:612-615.
10. Foote, P. A., Jr., and I. Brook. 1989. Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbiol flora. Arch. Otolaryngol. Head Neck Surg. 115:856-859.
11. Goldstein, E. J., D. M. Citron, C. V. Merriam, Y. Warren, K. L. Tyrrel, and H. Fernandez. 2003. In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis. Antimicrob. Agents Chemother. 47:1963-1967.
12. Mackowiak, P. A. 1982. The normal flora. N. Engl. J. Med. 307:83-93.
13. Murray, P. R., E. J. Barron, J. H. Jorgenson, M. A. Pfaller, and R. H. Yolken (ed.). 2003. Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
14. Murray, P. R., and J. E. Rosenblatt. 1976. Bacterial interference by oropharyngeal and clinical isolates of anaerobic bacteria. J. Infect. Dis. 134:281-285.
15. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial tests for bacteria that grow aerobically. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing. Supplement tables M100-S13/M7. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. O'Callaghan, D. H., A. Morris, S. M. Kirby, and A. H. Shingler. 1972. Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288.